Raymond James Financial Services Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-24,243
Closed -$283K 3285
2023
Q1
$283K Sell
24,243
-1,645
-6% -$21K ﹤0.01% 2676
2022
Q4
$275K Buy
25,888
+11,282
+77% +$109K ﹤0.01% 2648
2022
Q3
$142K Buy
+14,606
New +$193K ﹤0.01% 2933
2022
Q2
Sell
-11,157
Closed -$292K 3335
2022
Q1
$292K Buy
11,157
+6,053
+119% +$172K ﹤0.01% 2727
2021
Q4
$202K Sell
5,104
-2,315
-31% -$106K ﹤0.01% 2974
2021
Q3
$371K Buy
7,419
+21
+0.3% +$1.15K ﹤0.01% 2551
2021
Q2
$411K Buy
7,398
+286
+4% +$15.2K ﹤0.01% 2509
2021
Q1
$333K Sell
7,112
-1,620
-19% -$78.5K ﹤0.01% 2555
2020
Q4
$380K Buy
8,732
+2,716
+45% +$100K ﹤0.01% 2312
2020
Q3
$220K Sell
6,016
-4,716
-44% -$160K ﹤0.01% 2479
2020
Q2
$313K Buy
+10,732
New +$297K ﹤0.01% 2204

Other funds holding HCAT